Zhang X, Wang H, Yu M, Ma K, Ning L
Transl Cancer Res. 2022; 11(8):2834-2842.
PMID: 36093546
PMC: 9459642.
DOI: 10.21037/tcr-22-1736.
Patil S, Ali Baeshen H
Saudi J Biol Sci. 2021; 28(8):4613-4618.
PMID: 34354447
PMC: 8324949.
DOI: 10.1016/j.sjbs.2021.04.068.
Lopatina T, Grange C, Cavallari C, Navarro-Tableros V, Lombardo G, Rosso A
Oncogenesis. 2020; 9(10):90.
PMID: 33040091
PMC: 7548009.
DOI: 10.1038/s41389-020-00274-y.
Aaliyari-Serej Z, Ebrahimi A, Barazvan B, Ebrahimi-Kalan A, Hajiasgharzadeh K, Kazemi T
Adv Pharm Bull. 2020; 10(3):338-349.
PMID: 32665892
PMC: 7335982.
DOI: 10.34172/apb.2020.042.
Khatiwada P, Kannan A, Malla M, Dreier M, Shemshedini L
PeerJ. 2020; 8:e8921.
PMID: 32296610
PMC: 7151753.
DOI: 10.7717/peerj.8921.
Long non-coding RNA H19 mediates ovarian cancer cell cisplatin-resistance and migration during EMT.
Wu Y, Zhou Y, He J, Sun H, Jin Z
Int J Clin Exp Pathol. 2020; 12(7):2506-2515.
PMID: 31934077
PMC: 6949588.
Microarray‑based analysis of COL11A1 and TWIST1 as important differentially‑expressed pathogenic genes between left and right‑sided colon cancer.
Su C, Zhao J, Hong X, Yang S, Jiang Y, Hou J
Mol Med Rep. 2019; 20(5):4202-4214.
PMID: 31545476
PMC: 6797952.
DOI: 10.3892/mmr.2019.10667.
Enhanced metastatic potential in the MB49 urothelial carcinoma model.
Liu Y, Yin P, Silvers C, Lee Y
Sci Rep. 2019; 9(1):7425.
PMID: 31092844
PMC: 6520404.
DOI: 10.1038/s41598-019-43641-5.
2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol reverses EGF-induced cell migration and invasion through down-regulation of MDM2 in breast cancer cell lines.
Zheng D, Chang X, Liu Y, Xu J, Gou W, Li Z
Cancer Biol Ther. 2018; 20(4):513-523.
PMID: 30514153
PMC: 6422509.
DOI: 10.1080/15384047.2018.1537578.
Higher efficacy and complete response with administration of eribulin for recurrent squamous cell breast carcinoma: A case report.
Goto Y, Yoshida T, Kimura M
Mol Clin Oncol. 2018; 9(3):318-320.
PMID: 30155255
PMC: 6109669.
DOI: 10.3892/mco.2018.1676.
Loss of Twist1 in the Mesenchymal Compartment Promotes Increased Fibrosis in Experimental Lung Injury by Enhanced Expression of CXCL12.
Tan J, Tedrow J, Nouraie M, Dutta J, Miller D, Li X
J Immunol. 2017; 198(6):2269-2285.
PMID: 28179498
PMC: 5337810.
DOI: 10.4049/jimmunol.1600610.
Leptin promotes epithelial-mesenchymal transition of breast cancer via the upregulation of pyruvate kinase M2.
Wei L, Li K, Pang X, Guo B, Su M, Huang Y
J Exp Clin Cancer Res. 2016; 35(1):166.
PMID: 27769315
PMC: 5073421.
DOI: 10.1186/s13046-016-0446-4.
MicroRNA Regulation of Epithelial to Mesenchymal Transition.
Abba M, Patil N, Leupold J, Allgayer H
J Clin Med. 2016; 5(1).
PMID: 26784241
PMC: 4730133.
DOI: 10.3390/jcm5010008.
Twist promotes reprogramming of glucose metabolism in breast cancer cells through PI3K/AKT and p53 signaling pathways.
Yang L, Hou Y, Yuan J, Tang S, Zhang H, Zhu Q
Oncotarget. 2015; 6(28):25755-69.
PMID: 26342198
PMC: 4694864.
DOI: 10.18632/oncotarget.4697.
Twist1 is a potential prognostic marker for colorectal cancer and associated with chemoresistance.
Zhu D, Chen X, Zhang W, Wang J, Ouyang M, Zhong Q
Am J Cancer Res. 2015; 5(6):2000-11.
PMID: 26269759
PMC: 4529619.
The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?.
Plaks V, Kong N, Werb Z
Cell Stem Cell. 2015; 16(3):225-38.
PMID: 25748930
PMC: 4355577.
DOI: 10.1016/j.stem.2015.02.015.
Metaplastic breast cancer: clinical overview and molecular aberrations for potential targeted therapy.
Abouharb S, Moulder S
Curr Oncol Rep. 2015; 17(3):431.
PMID: 25691085
DOI: 10.1007/s11912-014-0431-z.
Fibroblast phenotypes in different lung diseases.
Du H, Chen D, Zhou Y, Han Z, Che G
J Cardiothorac Surg. 2014; 9:147.
PMID: 25189096
PMC: 4173054.
DOI: 10.1186/s13019-014-0147-z.
MYCN repression of Lifeguard/FAIM2 enhances neuroblastoma aggressiveness.
Planells-Ferrer L, Urresti J, Soriano A, Reix S, Murphy D, Ferreres J
Cell Death Dis. 2014; 5:e1401.
PMID: 25188511
PMC: 4540192.
DOI: 10.1038/cddis.2014.356.
Cadherin 11, a miR-675 target, induces N-cadherin expression and epithelial-mesenchymal transition in melasma.
Kim N, Choi S, Lee T, Lee C, Lee A
J Invest Dermatol. 2014; 134(12):2967-2976.
PMID: 24940649
DOI: 10.1038/jid.2014.257.